本页面由Tiger Trade Technology Pte. Ltd.提供服务

万达生物制药

5.00
+0.00500.10%
成交量:12.25万
成交额:61.02万
市值:3.02亿
市盈率:-1.08
高:5.03
开:5.00
低:4.95
收:4.99
52周最高:9.94
52周最低:4.27
股本:6,046.27万
流通股本:4,766.05万
量比:0.36
换手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-4.6291
每股收益(LYR):-3.7413
净资产收益率:-77.81%
总资产收益率:-22.38%
市净率:1.37
市盈率(LYR):-1.34

数据加载中...

2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

重要事件披露

8-K - Current report
2022/01/14

重要事件披露

8-K - Current report
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/30

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/28

重要事件披露

8-K - Current report
2021/06/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/10

重要事件披露

8-K - Current report
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals